Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
ConclusionOur results suggest that the site of metastasis is associated with prognosis in HER2-positive breast cancer, highlighted by the poor prognosis of liver metastases. Furthermore, liver metastases were associated with adverse tumour immune cell profiles.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Breast Cancer | Cancer | Cancer & Oncology | Computers | HER2 | Herceptin | Immunotherapy | Liver | Urology & Nephrology